Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis

Tuberculosis remains the biggest infectious threat to humanity with one-third of the population infected and 1.4 million deaths and 8.7 million new cases annually. Current tuberculosis therapy is lengthy and consists of multiple antimicrobials, which causes poor compliance and high treatment dropout...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Debapriya, Dwivedi, Ved Prakash, Maiga, Mamoudou, Maiga, Mariama, Van Kaer, Luc, Bishai, William R., Das, Gobardhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047417/
https://www.ncbi.nlm.nih.gov/pubmed/24711459
http://dx.doi.org/10.1074/jbc.M114.558098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047417/
https://www.ncbi.nlm.nih.gov/pubmed/24711459
http://dx.doi.org/10.1074/jbc.M114.558098

Ejemplares similares